[Controversies concerning oral anticoagulation control in primary care].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N Puche López.
Explore the source record for details and available documents.
OBJECTIVE: To find the rate of therapeutic control and the frequency of complications among patients receiving oral anticoagulant therapy, attending in a primary care center. DESIGN: Descriptive study over the last four years. SETTING: An urban primary care center. PATIENTS AND METHODS: We included all patients in oral anticoagulant treatment controlled in our center among 1989 and 1993, excluding that patients with less than three months in control, or discontinued control. The prothrombin time was measured by international normalized ratio (INR). To measure the therapeutic quality control, we used the method proposed by the International Society of Thrombosis and Haemostasis. The frequency of complications was measured in number of events/100 patients/year. RESULTS: In the 136 patients studied the average time in control was 23.57 months. The 68.37 percent of determinations were within satisfactory ranges. The frequency of minor hemorrhages was 13.36 by 100 patients/year, 1.08 of major hemorrhages, and 2.53 of thromboembolism events. CONCLUSIONS: The results obtained in this audit are similar to the communicated by other centers. The therapeutic control of oral anticoagulants can carry out in primary care with enough quality and some advantages: more facility to health education, better accessibility, and more integration of anticoagulation therapy in global care of patients.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Dominant autosomal polycystic renal disease (DAPRD) is the most common cystic nephropathy, with multiorgan expression in many cases. Chronic irreversible renal failure is its major complication. Its clinical presentation is variable and it may remain symptom-free; therefore, it is important to know its many renal and extrarenal features which may suggest the diagnosis together with the family history, and also indicate the diagnostic and therapeutic possibilities. The primary care physician may also play a role in prevention, with the early diagnosis of the involved patients and genetic counseling with information of the implications. We report 5 cases of DAPRD with a clinical evaluation and family study, and also a succinct literature review.
Explore the source record for details and available documents.
OBJECTIVE: To know the present situation about the follow-up of the patients with oral anticoagulant therapy (OAT) in primary care centers, the difficulties felt in its implantation and the professionals attitudes. DESIGN: Cross-sectional descriptive study. SETTING: All Spanish primary care centers. PARTICIPANTS: The study subjects are the managers of all primary care centers. We selected a sample of 227 centers (the total number is 1854), for prevalence of 50%, confidence at 95%, precision 7% and 30% loss. The sample is stratified by regions. MEASUREMENTS AND MAIN RESULTS: We sent a questionnaire by post to the managers of sample primary care centers. We sent a new mailing, after three months, to the "no answers". A rate of 72.7% answers were obtained. 23% of sample primary care centers do follow-up of OAT al less in a part of the patients. Reduced access to hospital is the only structural cause that it has influence significantly. The main problem to carry out this activity is coordination with Haematology reference service. CONCLUSIONS: One every four Spanish primary care centers make the follow-up of OAT, higher when primary care centers are far away from hospital. So, accessibility is the factor with more influence in the decision of carry out OAT follow-up. Coordination with haematology services is the main problem to solve.